Literature DB >> 9669398

Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images.

M B Imran1, K Kubota, S Yamada, H Fukuda, K Yamada, T Fujiwara, M Itoh.   

Abstract

UNLABELLED: The purpose of this study was to compare the diagnostic efficacy of attenuation-corrected and nonattenuation-corrected whole-body 18F-fluorodeoxyglucose (FDG) PET images to determine an adequate method that can semiquantitatively evaluate nonattenuation-corrected images.
METHODS: Whole-body PET studies were performed in 24 fasting patients with various tumors (lung cancers, n = 18; mediastinal tumors, n = 4; breast cancers, n = 2) 30-40 min after a bolus injection of 18F-FDG. Transmission scans followed emission data acquisition. Reconstructed attenuation-corrected and uncorrected images were displayed simultaneously and the relative FDG uptake in lesions and corresponding background areas was evaluated by the region of interest method. Both types of images were also compared with X-CT scans and conventional nuclear medicine scans for diagnostic efficacy.
RESULTS: Attenuation-corrected and uncorrected images were found to be equally sensitive for detecting lesions. There was a strong linear correlation between lesion-to-background (L/B) ratios calculated on attenuation-corrected and uncorrected images (r = 0.98; p < 0.001). Significant differences in L/B ratios between attenuation-corrected and uncorrected images were present in only 6 of 55 lesions (11%). Standardized uptake ratios (SURs) in attenuation-uncorrected images did not correlate with SURs in attenuation-corrected images nor with L/B ratios in uncorrected images.
CONCLUSION: The efficacy of attenuation-uncorrected FDG PET images in evaluating tumors is similar to that using attenuation-corrected images. Uncorrected images provide not only clinically useful but also quantitative information equivalent to that provided by attenuation-corrected images. However the L/B ratio is the only available index that can be used for quantification of uncorrected images.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669398

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images.

Authors:  Michael J Reinhardt; Nicole Wiethoelter; Alexander Matthies; Alexius Y Joe; Holger Strunk; Ursula Jaeger; Hans-Juergen Biersack
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-29       Impact factor: 9.236

2.  Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.

Authors:  Nanda C Krak; Jacobus J M van der Hoeven; Otto S Hoekstra; Jos W R Twisk; Elsken van der Wall; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-15       Impact factor: 9.236

3.  An evaluation of iterative reconstruction strategies based on mediastinal lesion detection using hybrid Ga-67 SPECT images.

Authors:  Nicholas F Pereira; Howard C Gifford; P Hendrik Pretorius; Mark Smyczynski; Robert Licho; Peter Schneider; Troy Farncombe; Michael A King
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

4.  Assessing Cutaneous Psoriasis Activity Using FDG-PET: Nonattenuation Corrected Versus Attenuation Corrected PET Images.

Authors:  Anshika Bakshi; Saeid Gholami; Abass Alavi; Joel M Gelfand; Junko Takeshita
Journal:  Clin Nucl Med       Date:  2015-09       Impact factor: 7.794

5.  Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe.

Authors:  Patrick Wunderbaldinger; Karl Turetschek; Christoph Bremer
Journal:  Eur Radiol       Date:  2003-06-12       Impact factor: 5.315

6.  Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma.

Authors:  V H Gerbaudo; S Britz-Cunningham; D J Sugarbaker; S T Treves
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

Review 7.  Attenuation-corrected vs. nonattenuation-corrected 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography in oncology: a systematic review.

Authors:  Urvi Joshi; Pieter G H M Raijmakers; Ingrid I Riphagen; Gerrit J J Teule; Arthur van Lingen; Otto S Hoekstra
Journal:  Mol Imaging Biol       Date:  2007 May-Jun       Impact factor: 3.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.